| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/22/2003 | US20030096838 Novel triazolo-pyridines anti-inflammatory compounds |
| 05/22/2003 | US20030096837 Clopidogrel bisulfate tablet formulation |
| 05/22/2003 | US20030096836 2-Aroylimidazole compounds for treating cancer |
| 05/22/2003 | US20030096834 Pharmaceutical compositions |
| 05/22/2003 | US20030096833 Use in inhibiting inflammation, cell death and in treating shock and reperfusion injuries |
| 05/22/2003 | US20030096832 Method of treating pain using nalbuphine and opioid antagonists |
| 05/22/2003 | US20030096831 Controlling postnatal ocular growth by ocular administration of a nicotinic antagonist |
| 05/22/2003 | US20030096830 Pyrrolo(3,2-d)pyrimidin-7-yl)-1,4-imino-D-ribitol derivatives; for suppression of T-cell function |
| 05/22/2003 | US20030096829 1-biaryl-1,8-naphthyridin-4-one phosphodiesterase-4 inhibitors |
| 05/22/2003 | US20030096828 Cyclic amide compound |
| 05/22/2003 | US20030096827 Heterocyclic amine derivatives; for treating an inflammatory or immune disease, a cardiovascular disease, or a neurodegenerative condition |
| 05/22/2003 | US20030096826 Inhibitors of interleukin-1 beta converting enzyme and other cysteine proteases in the ICE family |
| 05/22/2003 | US20030096825 Antiviral activity; treatment of HIV and AIDS |
| 05/22/2003 | US20030096824 Substituted phenylamidines medicaments containing said compounds and method for production thereof |
| 05/22/2003 | US20030096823 Method for the treatment of cardiotoxicity induced by antitumor compounds |
| 05/22/2003 | US20030096822 Comprises moxidectin, praziquantel, benzyl alcohol, ethanol, colloidal silicon dioxide, surfactant, and oil; veterinary medicine |
| 05/22/2003 | US20030096820 Nitrogen containing heterobicycles as factor Xa inhibitors |
| 05/22/2003 | US20030096819 Aryl and heteroaryl substituted fused pyrrole anti-inflammatory agents |
| 05/22/2003 | US20030096817 Inhibiting mammalian protein kinases (p38) with (2,6-difluoro-phenyl)-(5-iodo-pyridin-2-yl)amine for treatment of cardiovascular disorders |
| 05/22/2003 | US20030096816 Such as 2-methylsulfanyl-5-(2-phenylamino-pyrimidin-4-yl)-4-p-tolyl-thiophene-3 -carbonitrile; antiproliferative agents; stents |
| 05/22/2003 | US20030096815 Comprises triazine-based anticoccidial (claziril) for treating piroplasmosis with reduced side effects |
| 05/22/2003 | US20030096814 Isoxazolone compounds useful in treating diseases associated with unwanted cytokine activity |
| 05/22/2003 | US20030096812 Such as 1-cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-(4-amino-3-methyl-1 -piperidinyl)-4-oxo-quinoline-3-carboxylic acid for treatment of systemic or topical infections |
| 05/22/2003 | US20030096811 Such as cis-(4-dimethylaminomethyl-3-hydroxy-3-(3-methoxy-phenyl)-cyclohexanone for treatment of pain, inflammation, allergies, depression, drug/alcohol abuse, gastritis, itching, cardiovascular/repiratory diseases, epilepsy, and diarrhea |
| 05/22/2003 | US20030096810 Method and composition for restoring diuretic and renal function |
| 05/22/2003 | US20030096808 Comprises olanzapine (antipsychotic), divalproex sodium (mood stabilizer), and nizatidine (histamine H2-receptor antagonist) |
| 05/22/2003 | US20030096807 Arthroscopic irrigation solution and method for peripheral vasoconstriction and inhibition of pain and inflammation |
| 05/22/2003 | US20030096805 Antidepressants and their analogues as long-acting local anesthetics and analgesics |
| 05/22/2003 | US20030096802 Pentanoic acid derivatives |
| 05/22/2003 | US20030096801 Methods and compositions for the treatment of pain and other hormone-allergy-related symptoms using dilute hormone solutions |
| 05/22/2003 | US20030096800 Estrogenic compounds as anti-mitotic agents |
| 05/22/2003 | US20030096799 Novel 2-alkoxyestradiol analogs with antiproliferative and antimitotic activity |
| 05/22/2003 | US20030096798 Methods for the treatment or prophylaxis of aldosterone-mediated pathogenic effects in a subject using an epoxy-steroidal aldosterone antagonist |
| 05/22/2003 | US20030096797 Such as amifostine and a surfactant which enhances the biological activity; for subcutaneous administration; reducing toxicity of chemotherapy or radiotherapy; unit dosage forms |
| 05/22/2003 | US20030096796 N-cyanomethyl amides which are cysteine protease inhibitors; use treating diseases associated with activity of cathepsins B, K, L or S such as autoimmune disorders, allergic disorder, allogeneic immune response, cardiovascular disorders |
| 05/22/2003 | US20030096795 Calcium (3S) tetrahydro-3-furanyl (1S,2R)-3-[[(4-aminophenyl)sulfonyl](isobutyl)amino]-1-benzyl-2-(phos-phonooxy)propylcarbamate |
| 05/22/2003 | US20030096794 Compositions and kits comprising a defined boron compound, methods of their preparation, and use and administration thereof |
| 05/22/2003 | US20030096793 Inhibit protease enzymes; Benzyl 5-(benzoylamino)-4,4-dihydroxy-7- methyl-4-sila-octanamide, for example can be used to inhibit HIV protease in the treatment of AIDS |
| 05/22/2003 | US20030096792 Compositions comprising sibutramine metabolites in combination with phosphodiesterase inhibitors |
| 05/22/2003 | US20030096791 Taste masking of highly water-soluble drugs |
| 05/22/2003 | US20030096790 Bacterial antigens for an immunological test for infection of by a Grampositive bacterium; diagnosing infection associated with central venous catheters, prosthetic devices, and cerebrospinal fluid shunts |
| 05/22/2003 | US20030096789 For example, camptothecin derivatives such as irinotecan with capecitabine, gemcitabine or multi-targeted antifolate (MTA), also known as pemetrexed |
| 05/22/2003 | US20030096788 Adenosine derivatives |
| 05/22/2003 | US20030096787 Comprising the ITR sequences, a sequence permitting the encapsulation, a heterologous DNA sequence, and in which the E1 gene and at least one of the E2, E4 and L1-L5 genes is non-functional |
| 05/22/2003 | US20030096784 Oligoribonucleotides and oligoribonucleosides that have subsequences of 2'-pentoribofuranosyl nucleosides that activate dsRNase (double stranded RNAase) |
| 05/22/2003 | US20030096783 21132, a human G-protein coupled receptor family member and uses therefor |
| 05/22/2003 | US20030096782 Expression profiling in the intact human heart |
| 05/22/2003 | US20030096779 High molecular weight Dermatophagoides proteins, and nucleic acids encoding them; used to treat and diagnose mite allergies |
| 05/22/2003 | US20030096774 Compositions of nucleic acids and cationic aminoglycosides and methods of using and preparing the same |
| 05/22/2003 | US20030096771 8-50 nucleobases targeted to a nucleic acid molecule encoding hormone-sensitive lipase to hybridize with and inhibit expression |
| 05/22/2003 | US20030096770 Enhancement of the stability of oligonucleotides comprising phosphorothioate linkages by addition of water-soluble antioxidants |
| 05/22/2003 | US20030096769 Genetic molecules capable of modulating growth factor interaction with its receptor on epidermal keratinocytes |
| 05/22/2003 | US20030096766 Methods of and compositions for potentiating the action of agents active on cell wall sites of the susceptible bacteria |
| 05/22/2003 | US20030096765 Aromatic esters; cytotoxic agents; antitumor agents |
| 05/22/2003 | US20030096762 Compositions and methods for cystic fibrosis therapy |
| 05/22/2003 | US20030096761 Angiotensin converting enzyme (ACE) and/or neutral endopeptidase (NEP); organic acids and salts thereof, sodium lauryl sulfate and palmitoyl carnitine enhancers used in treating cardiovascular disorders |
| 05/22/2003 | US20030096744 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 05/22/2003 | US20030096737 Caspase inhibitors and uses thereof |
| 05/22/2003 | US20030096735 Use of melanin for inhibition of angiogenesis and macular degeneration |
| 05/22/2003 | US20030096705 Antagonists of MCP-1 function and methods of use thereof |
| 05/22/2003 | US20030096387 Contacting the isomerase with a compound having the structure: A-X-A, where A is radical which mimics the steric and electronic properties of phosphoserin and/or phosphothreonine residue, X= spacer, R is cyclic, heterocylic or aryl ring |
| 05/22/2003 | US20030096378 Process for the preparation of immunomodulatory polysaccharides from aloe |
| 05/22/2003 | US20030096376 Generation of autoinducer-2; obtain S-adenosylhomocysteine, incubate with preferential protein, allow conversion of s-adenosylhomocysteine to autoinducer-2 |
| 05/22/2003 | US20030096330 Genetically engineered cell for use as tool in controlling bacterial propagation and infection |
| 05/22/2003 | US20030096325 Evaluating human sensitivity to antitumor agents; obtain blood sample, monitor blood glutathione concentration, amplified concentration indicates sensitivity to antitumor agents |
| 05/22/2003 | US20030096287 Oligonucleotide for use as diagnostic tool in genetic engineering |
| 05/22/2003 | US20030096286 Oligoribonucleotides and ribonucleases for cleaving RNA |
| 05/22/2003 | US20030096270 Diagnosing respiratory disorder; obtain cells, monitor expression of marker gene, determine sequence, compare to control, detect polymorphism in polypeptide or nucleotide, presence of polymorphism indicates respiratory disorders |
| 05/22/2003 | US20030096266 Hydrophobic biopolymer for use in the treatment of infections, blood, inflammatory and muscular disorders |
| 05/22/2003 | US20030096050 Catechins; gallic acid or a salt thereof; anti-obesity agent with good taste |
| 05/22/2003 | US20030096030 Extracting materials from the shell of Xanthoceras sorbifolia Bunge and applying the extracted materials to making drugs and functional foods |
| 05/22/2003 | US20030096029 Remedies for allergic diseases and process for producing the same |
| 05/22/2003 | US20030096028 Novel hepatic disorder suppressant |
| 05/22/2003 | US20030096027 Alpha acid, (e.g., humulone) or beta acid (e.g., lupulone) |
| 05/22/2003 | US20030096022 Compositions and methods for the treatment and prevention of cardiovascular diseases and disorders, and for identifying agents therapeutic therefor |
| 05/22/2003 | US20030096019 Methods of using norfluoxetine |
| 05/22/2003 | US20030096018 Multi-vitamin and hormone replacement supplement |
| 05/22/2003 | US20030096015 Treating colon cancer with a mixture of 50% proteins-rich food, 30% lipids-rich food and 20% carbohydrates-rich food; e.g., 25% soybeans, 15% milk, 10% vegetables, 30% butter fats, 15% whole wheat and 5% fruits. |
| 05/22/2003 | US20030096014 Coprecipitate of itraconazole and a water-soluble nonpolymeric compound such as a nonvolatile acid. |
| 05/22/2003 | US20030096013 Seeding a drug in a first phase causing a phase change in the drug to a second phase of a desired polymorphic form |
| 05/22/2003 | US20030096012 Film-forming powder, compositions containing it, methods for their preparation and their uses |
| 05/22/2003 | US20030096008 Tetracycline - Doxycycline antibiotic composition |
| 05/22/2003 | US20030096007 Amoxicillin-dicloxacillin antibiotic composition |
| 05/22/2003 | US20030096006 Three dosage forms with different release profiles |
| 05/22/2003 | US20030096004 (S,S'),(S,R')-amphetaminil, compositions and uses thereof |
| 05/22/2003 | US20030096000 Encapsulation of nanosuspensions in liposomes and microspheres |
| 05/22/2003 | US20030095995 Formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents |
| 05/22/2003 | US20030095992 Altering a drug's distribution, metabolism and elimination properties, especially by modifying with aralkyl ester moieties to increase rate of metabolism to inactive and nontoxic metabolites when exposure is halted; surgery, riots |
| 05/22/2003 | US20030095963 Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restriced differentiation antigen for treatment of B cell lymphoma |
| 05/22/2003 | US20030095959 Topical skin composition |
| 05/22/2003 | US20030095958 Inhibiting beta amyloid converting enzyme responsible for A beta peptide cleavage to treat Alzheimer's Disease, Down's Syndrome, etc. |
| 05/22/2003 | US20030095947 Compositions and methods for elimination of unwanted cells |
| 05/22/2003 | US20030095940 Stimulation of said skin's stratum corneum turnover rate; also contains surfactant(s) and a chelating agent |
| 05/22/2003 | US20030095937 Method for stimulating hair growth by administering vitamin D analogs |
| 05/22/2003 | US20030095933 Anti-aging skin care composition and uses thereof |
| 05/22/2003 | US20030095927 Provides biologically active compounds for rapid absorption through the oral mucosa, resulting in fast onset of effect. |
| 05/22/2003 | US20030095926 Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the gastrointestinal tract or urinary tract |
| 05/22/2003 | US20030095925 For rapid absorption through the oral mucosa, resulting in fast onset of effect. |
| 05/22/2003 | CA2649826A1 Synthesis and purification of valacyclovir |
| 05/22/2003 | CA2477642A1 Formoterol tartrate process and polymorph |